-
Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination
Thursday, November 16, 2023 - 5:07pm | 436The duo comprised of clinical-stage natural psilocybin biotech Psyence Group Inc. and special purpose acquisition company Newcourt Acquisition Corp (NASDAQ: NCAC) announced that the SEC made effective a Form F-4 registration statement for a new business on November 13. Psyence Group...